Dr. Mark Clemons, Dr. Dean Fergusson and their colleagues at The Ottawa Hospital developed an efficient way for cancer patients to participate in clinical trials. Their program Rethinking Clinical Trials (REaCT) conducts practical patient-focused research to ensure patients receive optimal, safe, and cost effective treatment. It allows more patients to enter clinical trials by streamlining the process for obtaining oral, rather than written, patient consent, immediate randomization into treatment groups using a mobile device and simplified data collection. In just over 18 months, the REaCT program recruited 600 patients to participate in nine randomized trials.
“The REaCT program is fully committed to finding practical ways of improving the care of all cancer patients.”-- Dr. Mark Clemons
Find out more about made-in-Ottawa solutions for a healthier world at TenderLovingResearch.ca